New Results
P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cells
Robert J. Ihry, Kathleen A. Worringer, Max R. Salick, Elizabeth Frias, Daniel Ho, Kraig Theriault, Sravya Kommineni, Julie Chen, Marie Sondey, Chaoyang Ye, Ranjit Randhawa, Tripti Kulkarni, Zinger Yang, Gregory McAllister, Carsten Russ, John Reece-Hoyes, William Forrester, Gregory R. Hoffman, Ricardo Dolmetsch, Ajamete Kaykas
doi: https://doi.org/10.1101/168443
Robert J. Ihry
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Kathleen A. Worringer
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Max R. Salick
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Elizabeth Frias
2Department of Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Daniel Ho
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Kraig Theriault
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Sravya Kommineni
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Julie Chen
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Marie Sondey
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Chaoyang Ye
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Ranjit Randhawa
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Tripti Kulkarni
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Zinger Yang
2Department of Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Gregory McAllister
2Department of Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Carsten Russ
2Department of Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
John Reece-Hoyes
2Department of Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
William Forrester
2Department of Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Gregory R. Hoffman
2Department of Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Ricardo Dolmetsch
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Ajamete Kaykas
1Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
Article usage
Posted July 26, 2017.
P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cells
Robert J. Ihry, Kathleen A. Worringer, Max R. Salick, Elizabeth Frias, Daniel Ho, Kraig Theriault, Sravya Kommineni, Julie Chen, Marie Sondey, Chaoyang Ye, Ranjit Randhawa, Tripti Kulkarni, Zinger Yang, Gregory McAllister, Carsten Russ, John Reece-Hoyes, William Forrester, Gregory R. Hoffman, Ricardo Dolmetsch, Ajamete Kaykas
bioRxiv 168443; doi: https://doi.org/10.1101/168443
P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cells
Robert J. Ihry, Kathleen A. Worringer, Max R. Salick, Elizabeth Frias, Daniel Ho, Kraig Theriault, Sravya Kommineni, Julie Chen, Marie Sondey, Chaoyang Ye, Ranjit Randhawa, Tripti Kulkarni, Zinger Yang, Gregory McAllister, Carsten Russ, John Reece-Hoyes, William Forrester, Gregory R. Hoffman, Ricardo Dolmetsch, Ajamete Kaykas
bioRxiv 168443; doi: https://doi.org/10.1101/168443
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)